The Current Ratio as of November 2024 (TTM) for Inozyme Pharma, Inc. (INZY) is 7.68

According to Inozyme Pharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.68. This represents a change of -31.62% compared to the average of 11.24 of the last 4 quarters.

Inozyme Pharma, Inc. (INZY) Historical Current Ratio (quarterly & annually)

How has INZY Current Ratio performed in the past?

The mean historical Current Ratio of Inozyme Pharma, Inc. over the last ten years is 11.45. The current 7.68 Current Ratio has changed 6.61% with respect to the historical average. Over the past ten years (40 quarters), INZY's Current Ratio was at its highest in in the March 2021 quarter at 21.67. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Inozyme Pharma, Inc. (INZY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Inozyme Pharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Inozyme Pharma, Inc. (INZY) Average Current Ratio

How has INZY Current Ratio performed in the past?

The current Current Ratio of Inozyme Pharma, Inc. (INZY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Inozyme Pharma, Inc. (INZY) Current Ratio vs. Peers

How is INZY’s Current Ratio compared to its peers?

Inozyme Pharma, Inc.’s Current Ratio is less than Day One Biopharmaceuticals, Inc. (14.62), greater than X4 Pharmaceuticals, Inc. (4.89), less than Acumen Pharmaceuticals, Inc. (10.43), greater than Mereo BioPharma Group plc (6.10), less than Terns Pharmaceuticals, Inc. (32.99), greater than PDS Biotechnology Corporation (2.84), greater than HOOKIPA Pharma Inc. (3.26), greater than Eledon Pharmaceuticals, Inc. (6.53), greater than Amylyx Pharmaceuticals, Inc. (4.55),

Build a custom stock screener for Inozyme Pharma, Inc. (INZY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inozyme Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Inozyme Pharma, Inc. (INZY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Inozyme Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.